| Item | Current | Prior | YoY % |
|---|---|---|---|
| Net Sales | ¥11.02B | ¥9.87B | +11.7% |
| Cost of Sales | ¥9.02B | ¥8.10B | +11.4% |
| Gross Profit | ¥2.00B | ¥1.77B | +13.2% |
| SG&A Expenses | ¥897M | ¥895M | +0.2% |
| Operating Income | ¥1.10B | ¥872M | +26.6% |
| Non-operating Income | ¥34M | ¥80M | -57.5% |
| Non-operating Expenses | ¥30M | ¥20M | +50.0% |
| Ordinary Income | ¥1.11B | ¥932M | +18.9% |
| Profit Before Tax | ¥1.11B | ¥932M | +18.7% |
| Income Tax Expense | ¥354M | ¥301M | +17.6% |
| Net Income | ¥752M | ¥631M | +19.2% |
| Net Income Attributable to Owners | ¥752M | ¥631M | +19.2% |
| Total Comprehensive Income | ¥819M | ¥631M | +29.8% |
| Interest Expense | ¥29M | ¥16M | +81.2% |
| Basic EPS | ¥23.02 | ¥19.33 | +19.1% |
| Diluted EPS | ¥22.99 | ¥19.30 | +19.1% |
| Dividend Per Share | ¥0.00 | ¥0.00 | - |
| Item | Current End | Prior End | Change |
|---|---|---|---|
| Current Assets | ¥20.67B | ¥21.91B | ¥-1.24B |
| Cash and Deposits | ¥7.06B | ¥9.15B | ¥-2.09B |
| Accounts Receivable | ¥3.88B | ¥3.76B | +¥112M |
| Non-current Assets | ¥30.75B | ¥30.51B | +¥239M |
| Property, Plant & Equipment | ¥16.72B | ¥16.49B | +¥230M |
| Item | Value |
|---|---|
| Net Profit Margin | 6.8% |
| Gross Profit Margin | 18.2% |
| Current Ratio | 89.4% |
| Quick Ratio | 89.4% |
| Debt-to-Equity Ratio | 1.52x |
| Interest Coverage Ratio | 38.07x |
| Effective Tax Rate | 32.0% |
| Item | YoY Change |
|---|---|
| Net Sales YoY Change | +11.7% |
| Operating Income YoY Change | +26.5% |
| Ordinary Income YoY Change | +18.9% |
| Net Income Attributable to Owners YoY Change | +19.1% |
| Total Comprehensive Income YoY Change | +29.8% |
| Item | Value |
|---|---|
| Shares Outstanding (incl. Treasury) | 32.71M shares |
| Treasury Stock | 44K shares |
| Average Shares Outstanding | 32.67M shares |
| Book Value Per Share | ¥624.06 |
| Item | Amount |
|---|---|
| Q2 Dividend | ¥0.00 |
| Year-End Dividend | ¥34.00 |
| Segment | Revenue | Operating Income |
|---|---|---|
| NursingCare | ¥10.54B | ¥1.40B |
| Item | Forecast |
|---|---|
| Net Sales Forecast | ¥48.59B |
| Operating Income Forecast | ¥4.46B |
| Ordinary Income Forecast | ¥4.62B |
| Net Income Attributable to Owners Forecast | ¥3.09B |
| Basic EPS Forecast | ¥94.59 |
| Dividend Per Share Forecast | ¥20.00 |
| Intangible Assets | ¥2.58B | ¥2.61B | ¥-34M |
| Goodwill | ¥2.33B | ¥2.39B | ¥-55M |
| Investment Securities | ¥2.30B | ¥2.19B | +¥102M |
| Total Assets | ¥51.42B | ¥52.41B | ¥-996M |
| Current Liabilities | ¥23.11B | ¥23.58B | ¥-469M |
| Accounts Payable | ¥424M | ¥409M | +¥15M |
| Short-term Loans | ¥5.24B | ¥5.79B | ¥-548M |
| Non-current Liabilities | ¥7.92B | ¥8.15B | ¥-235M |
| Long-term Loans | ¥5.93B | ¥6.17B | ¥-241M |
| Total Liabilities | ¥31.03B | ¥31.74B | ¥-705M |
| Total Equity | ¥20.39B | ¥20.68B | ¥-291M |
| Capital Stock | ¥2.76B | ¥2.76B | ¥0 |
| Capital Surplus | ¥2.77B | ¥2.77B | ¥0 |
| Retained Earnings | ¥14.80B | ¥15.16B | ¥-359M |
| Treasury Stock | ¥-35M | ¥-35M | ¥0 |
| Owners' Equity | ¥20.35B | ¥20.64B | ¥-291M |
| Working Capital | ¥-2.44B | - | - |